Among women with class I obesity (BMI 30.034.9 kg/m), the pregnancy rate was 17.4% in the semaglutide group versus 25.5% in controls (OR = 0.61, 95% CI 0.390.97, p = 0.035), representing a statistically significant decrease
Gastroenterology 168(1):184185 Singh S, Chandan S, Dahiya DS, Aswath G, Ramai D, Maida M, Anderloni A, Muscatiello N, Facciorusso A (2024) Impact of GLP-1 receptor agonists in gastrointestinal endoscopy: an updated review
Preclinical evidence (strongest) Lee and colleagues (2015, Cell Metabolism ) showed MOTS-c reduced obesity and insulin resistance in mice on a high-fat diet
DSA was not performed
Before we dive in, sign up for our NNB Nutrition news alerts so you don't miss out on any of the novel ingredient developer's latest achievements: Subscribe to PricePlow's Newsletter and Alerts on These Topics Background on GLP-1 Signaling Our bodies have an incredibly sophisticated system for regulating metabolism and appetite, and at the center of this system is a hormone called glucagon-like peptide-1 (GLP-1)
This means more frequent follow-ups, goal-setting for weight and glucose metrics, and interdisciplinary collaboration
